血液学诊断试剂市场规模、份额、成长分析、按产品、按测试、按最终用户、按地区 - 按行业预测，2024-2031

2022年，血液学诊断试剂的全球市场规模为78亿美元，从2023年的82.4亿美元增长到2031年的128.5亿美元，在预测期内（2024-2031年）预计将以复合年增长率增长。

血液学诊断市场正在快速发展，主要是由于血液疾病的盛行率不断增加以及对及时、准确的诊断解决方案的需求不断增长。在自动化血液分析仪和可提高血液检测速度和准确性的就地检验设备等技术进步的推动下，该行业具有巨大的成长潜力。随着医疗保健专业人员寻求透过早期检测和量身定制的治疗方案来改善患者的治疗结果，该市场预计将会成长。然而，成本和对熟练人员的需求等挑战仍然存在。儘管存在这些障碍，但随着向个人化医疗的转变以及医疗保健提供者和研究人员优先考虑有效的血液疾病管理，这一领域为创新和成长提供了重要的机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

血液学诊断试剂市场规模：依产品分类

• 市场概况
• 装置
  • 分析仪
  • 流式细胞仪
• 消耗品
  • 试剂
  • 染色试剂
  • 其他的

血液学诊断试剂市场规模：按测试

• 市场概况
• 贫血
• 血红素疾病
• 白血病/淋巴瘤表型
• 血液学病理学
• 全血细胞计数
• 其他的

血液学诊断试剂市场规模：依最终用户划分

• 市场概况
• 医院
• 诊断实验室
• 其他的

血液学诊断试剂市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Sysmex Corporation（Japan）
• Danaher Corporation（USA）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Mindray（China）
• Bio-Rad Laboratories（USA）
• Nihon Kohden（Japan）
• Boule Diagnostics（Sweden）
• EKF Diagnostics（UK）
• Horiba（Japan）
• Roche Diagnostics（Switzerland）
• Beckman Coulter（USA）
• Diatron（Hungary）
• Erba Mannheim（Germany）
• Ortho Clinical Diagnostics（US）
• Cellavision（Sweden）
• Drucker Diagnostics（USA）
• Heska Corporation（USA）
• Neomedica（Germany）
• Thermo Fisher Scientific（USA）

结论和建议

Global Hematology Diagnostics Market size was valued at USD 7.8 billion in 2022 and is poised to grow from USD 8.24 billion in 2023 to USD 12.85 billion by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031).

The hematology diagnostics market is rapidly evolving, primarily due to the increasing incidence of blood disorders and a growing demand for timely and precise diagnostic solutions. This sector offers considerable growth potential, fueled by technological advancements, including automated hematology analyzers and point-of-care testing devices that enhance the speed and accuracy of blood testing. As healthcare professionals seek to improve patient outcomes through early detection and tailored treatment options, the market is poised for expansion. However, challenges such as cost and the need for skilled personnel persist. Despite these hurdles, the ongoing shift towards personalized medicine highlights significant opportunities for innovation and growth within the hematology diagnostics landscape, as providers and researchers prioritize effective blood disorder management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Diagnostics Market Segmental Analysis

Global Hematology Diagnostics Market is segmented by product, test, end user and region. Based on product, the market is segmented into instrument and consumables. Based on test, the market is segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count and others. Based on end user, the market is segmented into hospitals, diagnostics labs and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Diagnostics Market

The global hematology diagnostics market is significantly influenced by the rising incidence of blood disorders, including anemia, leukemia, and hemophilia. As these conditions become more prevalent, the need for precise and timely detection has surged, propelling the demand for advanced hematology diagnostic solutions. Healthcare providers are increasingly prioritizing early diagnosis and effective monitoring of blood-related ailments, leading to a greater consumption of specialized diagnostic tools and technologies. Consequently, this growing awareness and emphasis on blood health create substantial opportunities for industry players to innovate and expand their offerings within the hematology diagnostics sector, ultimately enhancing patient outcomes worldwide.

Restraints in the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market faces several restraints, one significant barrier being the high expense linked to hematology diagnostic instruments and reagents. These elevated costs can hinder market expansion, as the substantial initial investment required, coupled with ongoing maintenance expenses, may deter healthcare facilities from adopting these technologies. This challenge is especially pronounced in economically constrained healthcare environments, where budget limitations restrict access to advanced diagnostic solutions. Consequently, the financial burden posed by these sophisticated instruments can significantly impact their utilization, ultimately stalling growth in the hematology diagnostics sector.

Market Trends of the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid diagnosis and immediate treatment decisions directly at the patient's location. This shift is facilitated by advancements in portable and handheld hematology analyzers, which enhance the convenience and efficiency of testing in primary healthcare settings and emergency rooms. As healthcare providers seek to improve patient outcomes through timely interventions, the adoption of point-of-care solutions is expected to accelerate. This trend not only addresses the growing need for accessible diagnostics but also aligns with the broader movement towards personalized and immediate healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hematology Diagnostics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Instrument
  • Analyzer
  • Flow Cytometers
• Consumables
  • Reagents
  • Stains
  • Others

Global Hematology Diagnostics Market Size by Test & CAGR (2024-2031)

• Market Overview
• Anemia
• Hemoglobinopathy
• Leukemia/Lymphoma Phenotyping
• Hematology Pathophysiology
• Complete Blood Count
• Others

Global Hematology Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostics Labs
• Others

Global Hematology Diagnostics Market Size & CAGR (2024-2031)

• North America (Product, Test, End User)
  • US
  • Canada
• Europe (Product, Test, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diatron (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Mannheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellavision (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neomedica (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations